BIVI: BioVie Inc
BIVI exchange rate has changed by 1.61% for today. During the day, the instrument was traded at a low of 1.15 and at a high of 1.28.
Follow BioVie Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BIVI News
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- BioVie Reports Data From Phase 2 ADDRESS-LC Trial Of Bezisterim At 151st Annual Meeting Of American Neurological Association
- BioVie To Present Phase 2 Bezisterim Data In Long COVID, Parkinson’s At Neurology Conference October 18-19
- BioVie Inc. (BIVI) Discussion of Phase 2 data on bezisterim in Long COVID and Parkinson's with focus on inflammation targets Transcript
- BioVie Inc. (BIVI) Discusses Topline Phase 2 ADDRESS-LC Trial Data and the Potential of Bezisterim in Long Covid - Slideshow (NASDAQ:BIVI) 2026-09-17
- BioVie Inc. (BIVI) Discusses Topline Phase 2 ADDRESS-LC Trial Data and the Potential of Bezisterim in Long Covid Transcript
- BioVie Inc. (BIVI) Discusses Bezisterim Mechanism of Action and SUNRISE-PD Phase II Trial Design Transcript
- BioVie Inc. (BIVI) Discusses Clinical Updates on Bezisterim and BIV201 for Parkinson's, Alzheimer's, and Ascites Transcript
- BioVie Inc. (BIVI) Discusses Bezisterim's Mechanism of Action and Its Potential in Addressing Parkinson's Disease Pathology Transcript
- BioVie Inc. (BIVI) Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID Transcript
- BioVie completes enrollment for Parkinson’s drug trial
- What Makes BioVie (BIVI) a New Buy Stock
- BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease Transcript
- BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease - Slideshow (NASDAQ:BIVI) 2025-12-09
- BioVie shareholders approve amendment to equity incentive plan at annual meeting
Frequently Asked Questions
What is BIVI stock price today?
BioVie Inc stock is priced at 1.26 today. It trades within 1.15 - 1.28, yesterday's close was 1.24, and trading volume reached 223. The live price chart of BIVI shows these updates.
Does BioVie Inc stock pay dividends?
BioVie Inc is currently valued at 1.26. Dividend policy depends on the company, while investors also watch 0.00% and USD. View the chart live to track BIVI movements.
How to buy BIVI stock?
You can buy BioVie Inc shares at the current price of 1.26. Orders are usually placed near 1.26 or 1.56, while 223 and 4.13% show market activity. Follow BIVI updates on the live chart today.
How to invest into BIVI stock?
Investing in BioVie Inc involves considering the yearly range 0.82 - 3.79 and current price 1.26. Many compare -17.65% and -24.78% before placing orders at 1.26 or 1.56. Explore the BIVI price chart live with daily changes.
What are BioVie Inc stock highest prices?
The highest price of BioVie Inc in the past year was 3.79. Within 0.82 - 3.79, the stock fluctuated notably, and comparing with 1.24 helps spot resistance levels. Track BioVie Inc performance using the live chart.
What are BioVie Inc stock lowest prices?
The lowest price of BioVie Inc (BIVI) over the year was 0.82. Comparing it with the current 1.26 and 0.82 - 3.79 shows potential long-term entry points. Watch BIVI moves on the chart live for more details.
When did BIVI stock split?
BioVie Inc has gone through stock splits historically. These changes are visible in , 1.24, and 0.00% after corporate actions.
- Previous Close
- 1.24
- Open
- 1.21
- Bid
- 1.26
- Ask
- 1.56
- Low
- 1.15
- High
- 1.28
- Volume
- 223
- Daily Change
- 1.61%
- Month Change
- -17.65%
- 6 Months Change
- -24.78%
- Year Change
- 0.00%
- Act
- Fcst
- 198 K
- Prev
- 199 K
- Act
- Fcst
- 1.723 M
- Prev
- 1.710 M
- Act
- Fcst
- 0.0%
- Prev
- -0.1%
- Act
- Fcst
- Prev
- 1.955%